Patents by Inventor Lawren Wu

Lawren Wu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Apoptotic anti-IgE antibodies
    Patent number: 8071097
    Abstract: The present application relates to apoptotic anti-IgE antibodies, nucleic acid encoding the same, therapeutic compositions thereof, and their use in the treatment of IgE-mediated disorders.
    Type: Grant
    Filed: March 21, 2008
    Date of Patent: December 6, 2011
    Assignee: Genentech, Inc.
    Inventors: Lawren Wu, Mercedesz Balazs, Hans Brightbill, Andrew Chan, Yvonne Chen, Anan Chuntharapai, Mark Dennis, Terence Wong
  • Anti-Fc-gamma receptor antibodies, bispecific variants and uses therefor
    Patent number: 7662926
    Abstract: The present application describes antibodies that selectively bind human Fc?RIIB, with little or no binding to other human Fc?Rs, e.g., human Fc?RIIA. The invention also provides isolated bispecific antibodies comprising an antibody that selectively binds Fc?RIIB, and a second antibody that specifically binds an activating receptor. Various uses, including therapeutic uses, for those antibodies are also described, including administration with anti-tumor antibodies and methods of inhibiting immune responses and suppressing histamine release.
    Type: Grant
    Filed: January 18, 2007
    Date of Patent: February 16, 2010
    Assignee: Genentech, Inc.
    Inventors: Andrew C. Chan, Robert L. Shields, Lawren Wu
  • Anti-FC-gamma RIIB receptor antibody and uses therefor
    Patent number: 7655229
    Abstract: The present application describes antibodies that selectively bind human Fc?RIIB, with little or no binding to other human Fc?Rs, e.g., human Fc?RIIA. The invention also provides isolated bispecific antibodies comprising an antibody that selectively binds Fc?RIIB, and a second antibody that specifically binds an activating receptor. Various uses, including therapeutic uses, for those antibodies are also described, including administration with anti-tumor antibodies and methods of inhibiting immune responses and suppressing histamine release.
    Type: Grant
    Filed: April 16, 2007
    Date of Patent: February 2, 2010
    Inventors: Andrew C. Chan, Robert L. Shields, Lawren Wu
  • ANTI-FC-GAMMA RIIB RECEPTOR ANTIBODY AND USES THEREFOR
    Publication number: 20090087428
    Abstract: The present application describes antibodies that selectively bind human Fc?RIIB, with little or no binding to other human Fc?Rs, e.g., human Fc?RIIA. The invention also provides isolated bispecific antibodies comprising an antibody that selectively binds Fc?RIIB, and a second antibody that specifically binds an activating receptor. Various uses, including therapeutic uses, for those antibodies are also described, including administration with anti-tumor antibodies and methods of inhibiting immune responses and suppressing histamine release.
    Type: Application
    Filed: January 18, 2007
    Publication date: April 2, 2009
    Inventors: Andrew C. Chan, Robert L. Shields, Lawren Wu
  • Apoptotic Anti-IgE Antibodies
    Publication number: 20090010924
    Abstract: The present application relates to apoptotic anti-IgE antibodies, nucleic acid encoding the same, therapeutic compositions thereof, and their use in the treatment of IgE-mediated disorders.
    Type: Application
    Filed: March 21, 2008
    Publication date: January 8, 2009
    Applicant: GENENTECH, INC.
    Inventors: Lawren Wu, Mercedesz Balazs, Hans Brightbill, Andrew Chan, Yvonne Chen, Anan Chuntharapai, Mark Dennis, Terence Wong
  • Anti-FC-gamma RIIB receptor antibody and uses therefor
    Publication number: 20070253948
    Abstract: The present application describes antibodies that selectively bind human Fc?RIIB, with little or no binding to other human Fc?Rs, e.g., human Fc?RIIA. The invention also provides isolated bispecific antibodies comprising an antibody that selectively binds Fc?RIIB, and a second antibody that specifically binds an activating receptor. Various uses, including therapeutic uses, for those antibodies are also described, including administration with anti-tumor antibodies and methods of inhibiting immune responses and suppressing histamine release.
    Type: Application
    Filed: April 16, 2007
    Publication date: November 1, 2007
    Inventors: Andrew Chan, Robert Shields, Lawren Wu
  • Anti-Fc-gamma RIIB receptor antibody and uses therefor
    Publication number: 20060073142
    Abstract: The present application describes antibodies that selectively bind human FcyRIIB, with little or no binding to other human Fc?Rs, e.g., human Fc?RIIA. The invention also provides isolated bispecific antibodies comprising an antibody that selectively binds Fc?RIIB, and a second antibody that specifically binds an activating receptor. Various uses, including therapeutic uses, for those antibodies are also described, including administration with anti-tumor antibodies and methods of inhibiting immune responses and suppressing histamine release.
    Type: Application
    Filed: September 1, 2005
    Publication date: April 6, 2006
    Applicant: Genentech, Inc.
    Inventors: Andrew Chan, Robert Shields, Lawren Wu